Product Name: BAP3 Antibody
Species Reactivity: Human
Tested Applications: ELISA, IF, IHC-P, WB
Applications: BAP3 antibody can be used for the detection of BAP3 by Western blot at 2 μg/mL. Antibody can also be used for immunohistochemistry starting at 2.5 μg/mL. For immunofluorescence start at 20 μg/mL.
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight:
Immunogen: BAP3 antibody was raised against a 12 amino acid synthetic peptide from near the amino terminus of human BAP3.The immunogen is located within the first 50 amino acids of BAP3.
Host Species: Rabbit
Purification: BAP3 Antibody is affinity chromatography purified via peptide column.
Physical State: Liquid
CAS NO.: 100872-83-1
Product: ML346
Buffer: BAP3 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration: 1 mg/mL
Storage Conditions: BAP3 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: BAP3 Antibody: BAP3, KIAA0734, BAI1-associated protein 3, BAP3
Accession NO.: BAA34710
Protein Ino: 3929917
Official Symbol: BAIAP3
Geneid: 8938
Background: BAP3 Antibody: BRAL1 is a member a superfamily consisting of several highly homologous hyaluronan and proteoglycan binding link proteins. BRAL1 is predominantly expressed in brain tissue and spinal cord. Like other members in the link-module superfamily, BRAL1 contains an immunoglobulin-like fold and two proteoglycan tandem repeats (PTRs). Its mRNA expression pattern is similar to other lectican proteoglycans, suggesting that BRAL1 may act to stabilize the binding between the extracellular matrix molecule hyaluronan and brevican. Immunostaining of mouse brain showed BRAL1 expression at P20 in the white matter of the developing cerebellum and in myelinated fiber tracts in the adult brain, suggesting that expression starts when axonal myelination occurs.
PubMed ID:http://aac.asm.org/content/53/10/4508.abstract
